Icariin promotes cell proliferation and regulates gene expression in human neural stem cells in vitro

Yang,Pan; Guan,Yun‑Qian; Li,Ya‑Li; Zhang,Li; Zhang,Lan; Li,Lin

doi:10.3892/mmr.2016.5377

Icariin promotes cell proliferation and regulates gene expression in human neural stem cells in vitro

Authors:
- Pan Yang
- Yun‑Qian Guan
- Ya‑Li Li
- Li Zhang
- Lan Zhang
- Lin Li
View Affiliations

Affiliations: Department of Pharmacology, Xuanwu Hospital of Capital Medical University, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing 100053, P.R. China, Department of Cell Biology, Xuanwu Hospital of Capital Medical University, Beijing 100053, P.R. China
Published online on: June 8, 2016 https://doi.org/10.3892/mmr.2016.5377
Pages: 1316-1322

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Icariin (ICA), which is an essential bioactive component extracted from the herb Epimedium, possesses neuroprotective properties. The aim of the present study was to investigate the regulatory roles of ICA in cell proliferation and gene expression in human neural stem cells (NSCs) in vitro. Single cells were isolated from the corpus striatum of 16‑20‑week human fetuses obtained following spontaneous abortion. The cells were cultured in Dulbecco's modified Eagle's medium/F12 complete medium and were characterized by immunostaining and cell differentiation assay. NSCs were treated with ICA, and cell proliferation was assessed using the Cell Counting kit‑8 cell proliferation assay kit. In addition, neurosphere formation was comparatively studied between the ICA‑treated and control cells. cDNA microarray analysis was performed to examine the effects of ICA on gene expression. Altered expression of genes important for regulating NSC proliferation was further analyzed by quantitative polymerase chain reaction (qPCR). The results demonstrated that typical neurospheres appeared after 7‑10 days of culturing of individual cells isolated from the corpus striatum. These cells expressed nestin, an important NSC marker, and in the presence of differentiation medium they expressed β‑III‑tubulin, a specific neuronal marker, and glial fibrillary acidic protein, an astrocyte marker. Treatment with ICA enhanced NSC proliferation and the formation of neurospheres. Microarray data and pathway analysis revealed that the genes regulated by ICA were involved in several signaling pathways, including the Wnt and basic fibroblast growth factor (bFGF) pathways, which are important for the regulation of NSC function. Upregulation of frizzled class receptor 7 and dishevelled segment polarity protein 3, which are key players in the Wnt pathway, and fibroblast growth factor receptor 1, which is the receptor for bFGF, and downregulation of glycogen synthase kinase‑3β, which is a Wnt pathway inhibitor, was further validated by qPCR. In conclusion, ICA promoted proliferation and regulated gene expression in human NSCs, thus suggesting that ICA may exert its neuroprotective effects by regulating NSC activity.

View Figures

View References

1	Gage FH: Mammalian neural stem cells. Science. 287:1433–1438. 2000. View Article : Google Scholar : PubMed/NCBI
2	Zhang CL, Zou Y, He W, Gage FH and Evans RM: A role for adult TLX-positive neural stem cells in learning and behaviour. Nature. 451:1004–1007. 2008. View Article : Google Scholar : PubMed/NCBI
3	Thomas RM and Peterson DA: Even neural stem cells get the blues: Evidence for a molecular link between modulation of adult neurogenesis and depression. Gene Expr. 14:183–193. 2008.PubMed/NCBI
4	McBride JL, Behrstock SP, Chen EY, Jakel RJ, Siegel I, Svendsen CN and Kordower JH: Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J Comp Neurol. 475:211–219. 2004. View Article : Google Scholar : PubMed/NCBI
5	Carletti B, Piemonte F and Rossi F: Neuroprotection: The emerging concept of restorative neural stem cell biology for the treatment of neurodegenerative diseases. Curr Neuropharmacol. 9:313–317. 2011. View Article : Google Scholar : PubMed/NCBI
6	Waldau B, Hattiangady B, Kuruba R and Shetty AK: Medial ganglionic eminence-derived neural stem cell grafts ease spontaneous seizures and restore GDNF expression in a rat model of chronic temporal lobe epilepsy. Stem Cells. 28:1153–1164. 2010.PubMed/NCBI
7	Achanta P, Sedora Roman NI and Quiñones-Hinojosa A: Gliomagenesis and the use of neural stem cells in brain tumor treatment. Anticancer Agents Med Chem. 10:121–130. 2010. View Article : Google Scholar : PubMed/NCBI
8	Hung CW, Liou YJ, Lu SW, Tseng LM, Kao CL, Chen SJ, Chiou SH and Chang CJ: Stem cell-based neuroprotective and neurorestorative strategies. Int J Mol Sci. 11:2039–2055. 2010. View Article : Google Scholar : PubMed/NCBI
9	Yao R, Zhang L, Li X and Li L: Effects of Epimedium flavonoids on proliferation and differentiation of neural stem cells in vitro. Neurol Res. 32:736–742. 2010. View Article : Google Scholar
10	Pan Y, Kong L, Xia X, Zhang W, Xia Z and Jiang F: Antidepressant-like effect of icariin and its possible mechanism in mice. Pharmacol Biochem Behav. 82:686–694. 2005. View Article : Google Scholar : PubMed/NCBI
11	Xu CQ, Liu BJ, Wu JF, Xu YC, Duan XH, Cao YX and Dong JC: Icariin attenuates LPS-induced acute inflammatory responses: Involvement of PI3K/Akt and NF-kappaB signaling pathway. Eur J Pharmacol. 642:146–153. 2010. View Article : Google Scholar : PubMed/NCBI
12	Urano T and Tohda C: Icariin improves memory impairment in Alzheimer's disease model mice (5xFAD) and attenuates amyloid β-induced neurite atrophy. Phytother Res. 24:1658–1663. 2010. View Article : Google Scholar : PubMed/NCBI
13	Tohda C and Nagata A: Epimedium koreanum extract and its constituent icariin improve motor dysfunction in spinal cord injury. Evid Based Complement Alternat Med. 2012:7312082012. View Article : Google Scholar : PubMed/NCBI
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
15	Messam CA, Hou J and Major EO: Coexpression of nestin in neural and glial cells in the developing human CNS defined by a human-specific anti-nestin antibody. Exp Neurol. 161:585–596. 2000. View Article : Google Scholar : PubMed/NCBI
16	Katsetos CD, Herman MM and Mörk SJ: Class III beta-tubulin in human development and cancer. Cell Motil Cytoskeleton. 55:77–96. 2003. View Article : Google Scholar : PubMed/NCBI
17	Menet V, Giménez y Ribotta M, Chauvet N, Drian MJ, Lannoy J, Colucci-Guyon E and Privat A: Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression. J Neurosci. 21:6147–6158. 2001.PubMed/NCBI
18	Schena M, Shalon D, Davis RW and Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 270:467–470. 1995. View Article : Google Scholar : PubMed/NCBI
19	Lie DC, Colamarino SA, Song HJ, Désiré L, Mira H, Consiglio A, Lein ES, Jessberger S, Lansford H, Dearle AR and Gage FH: Wnt signalling regulates adult hippocampal neurogenesis. Nature. 437:1370–1375. 2005. View Article : Google Scholar : PubMed/NCBI
20	Wexler EM, Paucer A, Kornblum HI, Palmer TD and Geschwind DH: Endogenous Wnt signaling maintains neural progenitor cell potency. Stem Cells. 27:1130–1141. 2009. View Article : Google Scholar : PubMed/NCBI
21	Machon O, Backman M, Machonova O, Kozmik Z, Vacik T, Andersen L and Krauss S: A dynamic gradient of Wnt signaling controls initiation of neurogenesis in the mammalian cortex and cellular specification in the hippocampus. Dev Biol. 311:223–237. 2007. View Article : Google Scholar : PubMed/NCBI
22	Reimers D, López-Toledano MA, Mason I, Cuevas P, Redondo C, Herranz AS, Lobo MV and Bazán E: Developmental expression of fibroblast growth factor (FGF) receptors in neural stem cell progeny. Modulation of neuronal and glial lineages by basic FGF treatment. Neurol Res. 23:612–621. 2001. View Article : Google Scholar : PubMed/NCBI
23	Kelly CM, Tyers P, Borg MT, Svendsen CN, Dunnett SB and Rosser AE: EGF and FGF-2 responsiveness of rat and mouse neural precursors derived from the embryonic CNS. Brain Res Bull. 68:83–94. 2005. View Article : Google Scholar : PubMed/NCBI
24	Nelson AD and Svendsen CN: Low concentrations of extracellular FGF-2 are sufficient but not essential for neurogenesis from human neural progenitor cells. Mol Cell Neurosci. 33:29–35. 2006. View Article : Google Scholar : PubMed/NCBI
25	Furusho M, Kaga Y, Ishii A, Hébert JM and Bansal R: Fibroblast growth factor signaling is required for the generation of oligoden-drocyte progenitors from the embryonic forebrain. J Neurosci. 31:5055–5066. 2011. View Article : Google Scholar : PubMed/NCBI
26	Clevers H and Nusse R: Wnt/β-catenin signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
27	Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A and Lee E: The way Wnt works: Components and mechanism. Growth Factors. 31:1–31. 2013. View Article : Google Scholar :
28	Dann CE, Hsieh JC, Rattner A, Sharma D, Nathans J and Leahy DJ: Insights into Wnt binding and signaling from the structures of two Frizzled cysteine-rich domains. Nature. 412:86–90. 2001. View Article : Google Scholar : PubMed/NCBI
29	Wallingford JB and Habas R: The developmental biology of dishevelled: An enigmatic protein governing cell fate and cell polarity. Development. 132:4421–4436. 2005. View Article : Google Scholar : PubMed/NCBI
30	Gan XQ, Wang JY, Xi Y, Wu ZL, Li YP and Li L: Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction. J Cell Biol. 180:1087–1100. 2008. View Article : Google Scholar : PubMed/NCBI
31	Hart MJ, de los Santos R, Albert IN, Rubinfeld B and Polakis P: Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol. 8:573–581. 1998. View Article : Google Scholar : PubMed/NCBI